Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -19.88 | 16.25 |
PEG Ratio (TTM) | -2.27 | 1.70 |
P/S Ratio (TTM) | 2.38 | 2.61 |
P/B Ratio (TTM) | 0.85 | 1.90 |
P/FCF Ratio (TTM) | -30.85 | 11.14 |
Price to 5YR AVG Earnings Ratio | N/A | 14.10 |
Price to 5YR AVG FCF Ratio | N/A | 8.07 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.49% | 1,502.82% |
ROE (TTM) | -4.21% | 8.88% |
Net Profit Margin (TTM) | -11.23% | 15.60% |
ROIC 5YR AVG | N/A | 20.57% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -164.95% | 73.39% | N/A |
Revenue | 22.68% | 10.69% | N/A |
Net Income | -145.90% | 59.54% | N/A |
Cash Flow | 15.74% | 20.38% | N/A |
Health (28%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.98 | 3.19 |
Quick Ratio (TTM) | 9.49 | 4.91 |
D/E Ratio (TTM) | 1.38 | 1.27 |
Interest Coverage (TTM) | 0.35 | 0.64 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | 0.25 | 0.38 |
LTL to 5YR AVG FCF | N/A | 6.26 |
Shares Outstanding Growth 5YR AVG | N/A | 4.88% |